(Q31139620)

29 June 2017

Human recombinant neutralizing antibodies against hantaan virus G2 protein (English)

1 reference

29 June 2017

1 reference

1 reference

2

Mifang Liang

1 reference

29 June 2017

Joachim Koch

1

1 reference

29 June 2017

Iris Queitsch

series ordinal

3

1 reference

29 June 2017

Annette A. Kraus

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706090

26 December 2023

Ekkehard K. F. Bautz

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706090

26 December 2023

language of work or name

English

0 references

publication date

1 March 2003

1 reference

29 June 2017

30 March 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12706090

full work available at URL

26 December 2023

https://doi.org/10.1016/s0042-6822(02)00094-6

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706090

https://api.elsevier.com/content/article/PII:S0042682202000946?httpAccept=text/xml

26 December 2023

1 reference

10.1016/S0042-6822(02)00094-6

DOI

https://api.crossref.org/works/10.1016/S0042-6822(02)00094-6

https://api.elsevier.com/content/article/PII:S0042682202000946?httpAccept=text/plain

26 December 2023

1 reference

10.1016/S0042-6822(02)00094-6

DOI

https://api.crossref.org/works/10.1016/S0042-6822(02)00094-6

26 December 2023

1 reference

29 June 2017

308

1 reference

29 June 2017

1

1 reference

29 June 2017

64-73

1 reference

Hemorrhagic fever with renal syndrome in Greece: clinical and laboratory characteristics.

29 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900094-6

7 January 2021

Characterization of Hantaan virus envelope glycoprotein antigenic determinants defined by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900094-6

7 January 2021

Protective role of antigenic sites on the envelope protein of Hantaan virus defined by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900094-6

7 January 2021

Genetic and antigenic properties of Dobrava virus: a unique member of the Hantavirus genus, family Bunyaviridae

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900094-6

7 January 2021

Assembly of combinatorial antibody libraries on phage surfaces: the gene III site

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900094-6

7 January 2021

beta3 Integrins mediate the cellular entry of hantaviruses that cause respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900094-6

7 January 2021

Molecular determinants of the virulence and infectivity of California serogroup bunyaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900094-6

7 January 2021

Expression of a human, neutralizing monoclonal antibody specific to puumala virus G2-protein in stably-transformed insect cells

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900094-6

7 January 2021

Identification of a cell surface 30 kDa protein as a candidate receptor for Hantaan virus

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900094-6

7 January 2021

Phage-displayed peptides mimicking the discontinuous neutralization sites of puumala Hantavirus envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900094-6

7 January 2021

A chemiluminescence detection method of hantaviral antigens in neutralisation assays and inhibitor studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900094-6

7 January 2021

Isolation of Hantaan virus, the etiologic agent of Korean hemorrhagic fever, from wild urban rats

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900094-6

7 January 2021

Isolation of the Etiologic Agent of Korean Hemorrhagic Fever

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900094-6

7 January 2021

Bacterial expression of neutralizing mouse monoclonal antibody Fab fragments to Hantaan virus

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900094-6

7 January 2021

Baculovirus expression cassette vectors for rapid production of complete human IgG from phage display selected antibody fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900094-6

7 January 2021

Baculovirus expression of a human G2-specific, neutralizing IgG monoclonal antibody to Puumala virus

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900094-6

7 January 2021

Generation of an HFRS patient-derived neutralizing recombinant antibody to Hantaan virus G1 protein and definition of the neutralizing domain

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900094-6

7 January 2021

Isolation of haemorrhagic fever with renal syndrome virus from leukocytes of rats and virus replication in cultures of rat and human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900094-6

7 January 2021

Isolation of the nephropathia epidemica agent in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900094-6

7 January 2021

Antibody-selectable filamentous fd phage vectors: affinity purification of target genes

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900094-6

7 January 2021

Human recombinant Puumala virus antibodies: cross-reaction with other hantaviruses and use in diagnostics.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900094-6

7 January 2021

Comparability testing of a humanized monoclonal antibody (Synagis) to support cell line stability, process validation, and scale-up for manufacturing

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900094-6

7 January 2021

Conservation of antigenic properties and sequences encoding the envelope proteins of prototype Hantaan virus and two virus isolates from Korean haemorrhagic fever patients

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900094-6

7 January 2021

Analysis of Hantaan virus RNA: evidence for a new genus of bunyaviridae

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900094-6

7 January 2021

Hantaviruses: A Global Disease Problem

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900094-6

7 January 2021

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900094-6

7 January 2021

An unusual hantavirus outbreak in southern Argentina: person-to-person transmission? Hantavirus Pulmonary Syndrome Study Group for Patagonia

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900094-6

7 January 2021

Antibody-dependent enhancement of hantavirus infection in macrophage cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900094-6

7 January 2021

Characteristics of passive immunity against hantavirus infection in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2802%2900094-6

7 January 2021

10.1016/S0042-6822(02)00094-6

Identifiers

DOI

1 reference

29 June 2017

1 reference